Qian Ruan

Qian Ruan, Ph.D., is the Vice President of Technical Operations and Manufacturing of Arcturus Therapeutics. Dr. Ruan is responsible for mRNA drug substance and LNP drug product productions at CMOs, as well as managing ARCALIS (Japan) and Vinbio (Vietnam) tech transfer. Dr. Ruan has extensive experience in bioprocess development from preclinical to licensure. Prior to Arcturus, Dr. Ruan worked at Emergent BioSolutions/PaxVax Inc. as Sr. Director of Process Development and Clinical Production. She has successfully built and led the team developed/manufactured/tech transferred oral delivery vectors and injectable virus-like particles for vaccines. She was the main contributor for multiple Investigational new drug (IND) and Biological Licensure Application (BLA) submissions. Prior to Emergent BioSolutions/ PaxVax Inc, she worked for the Center of Cell and Gene Therapy at Baylor College of Medicine and developed early phase gene therapy drugs with adenovirus, herpes, and retrovirus platform technology. She published multiple articles and was the co-author of chapter ‚ÄúPurification of Adenovirus‚ÄĚ in the book Adenoviral vectors for Gene Therapy. Dr. Ruan holds a Ph.D. and a Bachelor's degree in Biochemical Engineering from South China University of Technology.